The issuer evidence gap in tokenised private markets

Tokenised private credit, tokenised funds and tokenised real-world asset programmes have a communications pattern. There is a product name, a yield figure, a chain, a logo set of 'partners', and a white paper or one-pager. There is often not a comparably prominent statement of the issuing legal person, its owners, the instrument's legal rights, the valuation policy, the custodian, the transfer restrictions, and the date of the last disclosure update.

The sample and the method

RCA reviewed a defined public sample of tokenised private-market and tokenised-fund offerings: product sites, white papers, fund documents where available, company-register extracts, and regulator registers in the EU, UK, US, Singapore and Switzerland. We asked the same eight questions of each file. A 'yes' required a primary or official-issuer source, dated, that a third party could retrieve. Marketing copy did not count.

• Legal issuer identity (name, number, formation jurisdiction).
• Control / beneficial ownership to a lawful public standard.
• Instrument rights (claim, equity, contractual, deposit, fund interest).
• Valuation or reserve methodology.
• Custody and cash-agent arrangements.
• Transfer restrictions and eligible-investor perimeter.
• Smart-contract administration and upgrade control.
• Disclosure-update history with dates.

On that method, evidence coverage is typically fragmented. Registered US funds and MiCA EMT issuers cluster toward the strong end of the range—because the underlying regime already demands a document set. Private credit and 'RWA' origination vehicles cluster toward limited or fragmented, even when the technology vendors are well known. The gap is not mainly a chain-data gap. It is an issuer-document gap.

Why it matters

Asset managers, exchanges, custodians, fund administrators and institutional investors cannot make defensible onboarding decisions from promotional material. Venue listing, banking, and fund-administration controls all assume an entity that can be identified, a right that can be described, and a document that can be archived. A token contract address answers none of those questions on its own.

The regulatory overlay

MiCA, UK promotions and FSMA design, US securities and 1940 Act rules, MAS licensing and Swiss DLT law each bite on different structures. A tokenised US money-market fund, a BVI note, and an EU ART are not the same instrument. RCA's finding is not that they should be. It is that public evidence for the issuer layer is systematically thinner than public evidence for the product layer, and that this is a market-structure problem rather than a journalism problem.

The evidence pack a serious issuer should maintain

• Entity: constitutional documents, register extract, LEI where held.
• Owners: beneficial-ownership disclosure to the standard the home regime requires.
• Rights: terms, prospectus or offering memorandum, clearly stating what the token is not.
• Disclosures: dated white paper or fund reports, with a change log.
• Audits and attestations: scope, standard, as-of date, and the legal person they cover.
• Contract controls: admin keys, pause, upgrade, and who holds them.
• Reporting history: what was published, when, and what was corrected.

The RCA view

Evidence coverage in tokenised private markets is fragmented. It is improving at the regulated-fund and EMT end of the spectrum. It is not improving as quickly where origination vehicles sit offshore and the public interface is a website. That is a conclusion about public evidence, not about investment quality, and not about whether any named programme is 'compliant'.